Clinical efficacy and tolerability of direct-acting antivirals in elderly patients with chronic hepatitis C

BACKGROUND: There is a lack of evidence-based data on aged patients with newer direct-acting antivirals (DAAs) and with shorter duration of treatment regimens involving DAAs with or without ribavirin (RBV) and pegylated interferon (Peg IFN). PATIENTS AND METHODS: Medical records of 240 patients trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Sherigar, Jagannath M., Gayam, Vijay, Khan, Arifa, Mukhtar, Osama, Arefiev, Yavgeniy, Khalid, Mazin, Siddiqui, Imran, Rangaraju, Ayyappa M., Budhathoki, Nibash, Mansour, Mohammed, Guss, Debra, Mohanty, Smruti R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams And Wilkins 2017
Materias:
Original Articles: Hepatitis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459584/
https://www.ncbi.nlm.nih.gov/pubmed/28346233
http://dx.doi.org/10.1097/MEG.0000000000000871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459584/
https://www.ncbi.nlm.nih.gov/pubmed/28346233
http://dx.doi.org/10.1097/MEG.0000000000000871

Ejemplares similares